Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The Associate Director, Study Start-up (SSU), Oncology is accountable for the end-to-end delivery of site start-up activities across clinical studies, from site identification through site activation. This role works in close collaboration with the Clinical Project Manager (CPM) and/or Clinical Operations Study Lead and serves as an active member of one or more study teams. The Associate Director leads the strategy development and execution of global site identification, feasibility, and selection for new and ongoing oncology trials. This position requires close collaboration with cross-functional stakeholders and external vendors involved in site selection and activation processes. The role also includes line management responsibilities for the Clinical Operations Study Start-up team, with accountability for team performance, capability development, and compliance with applicable SOPs and regulatory requirements.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level